Mechanisms of resistance of bacteria causing ventilator-associated pneumonia

Clinics in Chest Medicine

Volumn 26, Issue 1, 2005, Pages 75-79

  Szabo, Dora ^a   Silveira, Fernanda ^a   Fujitani, Shigeki ^a   Paterson, David L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CEPHAMYCIN; IMIPENEM; LINEZOLID; MEROPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; DEVICE INFECTION; DRUG ACTIVITY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; UPREGULATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 15744387375     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.10.004     Document Type: Review

References (30)

1. M.J. Richards, J.R. Edwards, and D.H. Culver Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System Crit Care Med 27 1999 887 892
2. M.H. Kollef, J. Rello, and S.K. Cammarata Clinical cure and survival in gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin Intensive Care Med 30 2004 388 394
3. R.G. Wunderink, J. Rello, and S.K. Cammarata Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia Chest 124 2003 1789 1797
4. R.G. Wunderink, S.K. Cammarata, and T.H. Oliphant Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia Clin Ther 25 2003 980 992
5. N.K. Shrestha, M.J. Tuohy, and G.S. Hall Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ALERT blood culture bottles by using the LightCycler system J Clin Microbiol 40 2002 2659 2661
6. S. Chang, D.M. Sievert, and J.C. Hageman Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 2003 1342 1347
7. T.L. Smith, M.L. Pearson, and K.R. Wilcox Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group N Engl J Med 340 1999 493 501
8. W.C. Noble, Z. Virani, and R.G. Cree Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus FEMS Microbiol Lett 72 1992 195 198
9. S.K. Pillai, G. Sakoulas, and C. Wennersten Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype J Infect Dis 186 2002 1603 1607
10. S. Tsiodras, H.S. Gold, and G. Sakoulas Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 358 2001 207 208
11. P. Wilson, J.A. Andrews, and R. Charlesworth Linezolid resistance in clinical isolates of Staphylococcus aureus J Antimicrob Chemother 51 2003 186 188
12. D.L. Paterson, A.W. Pasculle, and K. McCurry Linezolid: the first oxazolidinone antimicrobial Ann Intern Med 139 2003 863 864
13. S.H. Marshall, C.J. Donskey, and R. Hutton-Thomas Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis Antimicrob Agents Chemother 46 2002 3334 3336
14. K. Bush, G.A. Jacoby, and A.A. Medeiros A functional classification scheme for beta-lactamases and its correlation with molecular structure Antimicrob Agents Chemother 39 1995 1211 1233
15. T. Naas, and P. Nordmann OXA-type beta-lactamases Curr Pharm Des 5 1999 865 879
16. V. Dubois, C. Arpin, and C. Quentin Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase Antimicrob Agents Chemother 47 2003 2380 2381
17. C. Heritier, L. Poirel, and D. Aubert Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii Antimicrob Agents Chemother 47 2003 268 273
18. A.P. Gibb, C. Tribuddharat, and R.A. Moore Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7) Antimicrob Agents Chemother 46 2002 255 258
19. G. Cornaglia, A. Mazzariol, and L. Lauretti Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase Clin Infect Dis 31 2000 1119 1125
20. J.J. Yan, P.R. Hsueh, and W.C. Ko Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme Antimicrob Agents Chemother 45 2001 2224 2228
21. D.M. Livermore Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34 2002 634 640
22. H. Knothe, P. Shah, and V. Krcmery Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens Infection 11 1983 315 317
23. D.L. Paterson, W.C. Ko, and A. Von Gottberg Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 2212
24. D.M. Livermore Beta-lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557 584
25. J.W. Chow, M.J. Fine, and D.M. Shlaes Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 1991 585 590
26. K.S. Kaye, S. Cosgrove, and A. Harris Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp Antimicrob Agents Chemother 45 2001 2628 2630
27. K.S. Thomson, and E.S. Moland Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae Antimicrob Agents Chemother 45 2001 3548 3554
28. E. Lautenbach, B.L. Strom, and W.B. Bilker Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae Clin Infect Dis 33 2001 1288 1294
29. D.L. Paterson, L. Mulazimoglu, and J.M. Casellas Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia Clin Infect Dis 30 2000 473 478
30. L. Martinez-Martinez, A. Pascual, and G.A. Jacoby Quinolone resistance from a transferable plasmid Lancet 351 1998 797 799